Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 907 | 2021 |
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ... Nature 596 (7870), 109-113, 2021 | 698 | 2021 |
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans JS Turner, W Kim, E Kalaidina, CW Goss, AM Rauseo, AJ Schmitz, ... Nature 595 (7867), 421-425, 2021 | 548 | 2021 |
Gr1+ inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii IR Dunay, RA DaMatta, B Fux, R Presti, S Greco, M Colonna, LD Sibley Immunity 29 (2), 306-317, 2008 | 515 | 2008 |
Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs TA Fehniger, SF Cai, X Cao, AJ Bredemeyer, RM Presti, AR French, ... Immunity 26 (6), 798-811, 2007 | 495 | 2007 |
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor–sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized … JL Lennox, RJ Landovitz, HJ Ribaudo, I Ofotokun, LH Na, C Godfrey, ... Annals of internal medicine 161 (7), 461-471, 2014 | 309 | 2014 |
Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome SA Handley, LB Thackray, G Zhao, R Presti, AD Miller, L Droit, P Abbink, ... Cell 151 (2), 253-266, 2012 | 302 | 2012 |
Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, EG Demissie, ... Annals of internal medicine 174 (11), 1572-1585, 2021 | 284 | 2021 |
Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels RM Presti, JL Pollock, AJ Dal Canto, AK O'Guin, HW Virgin IV The Journal of experimental medicine 188 (3), 577-588, 1998 | 267 | 1998 |
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm PA Mudd, JC Crawford, JS Turner, A Souquette, D Reynolds, D Bender, ... Science advances 6 (50), eabe3024, 2020 | 226 | 2020 |
Human germinal centres engage memory and naive B cells after influenza vaccination JS Turner, JQ Zhou, J Han, AJ Schmitz, AA Rizk, WB Alsoussi, T Lei, ... Nature 586 (7827), 127-132, 2020 | 225 | 2020 |
Germinal centre-driven maturation of B cell response to mRNA vaccination W Kim, JQ Zhou, SC Horvath, AJ Schmitz, AJ Sturtz, T Lei, Z Liu, ... Nature 604 (7904), 141-145, 2022 | 224 | 2022 |
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ... Cell 185 (4), 603-613. e15, 2022 | 216 | 2022 |
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ... Science immunology 6 (59), eabh2259, 2021 | 189 | 2021 |
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice HW Virgin IV, RM Presti, XY Li, C Liu, SH Speck Journal of virology 73 (3), 2321-2332, 1999 | 174 | 1999 |
Latent murine cytomegalovirus infection in macrophages JL Pollock, RM Presti, S Paetzold, HWV IVth Virology 227 (1), 168-179, 1997 | 161 | 1997 |
Phospholipase C-γ2 is a critical signaling mediator for murine NK cell activating receptors I Tassi, R Presti, S Kim, WM Yokoyama, S Gilfillan, M Colonna The Journal of Immunology 175 (2), 749-754, 2005 | 152 | 2005 |
Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2 P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, AA El-Qunni, A Haile, ... MedRxiv, 2021 | 145 | 2021 |
Quaranfil, Johnston Atoll, and Lake Chad Viruses Are Novel Members of the Family Orthomyxoviridae RM Presti, G Zhao, WL Beatty, KA Mihindukulasuriya, ... Journal of virology 83 (22), 11599-11606, 2009 | 145 | 2009 |
A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older: AIDS Clinical … TJ Wilkin, H Chen, MS Cespedes, JT Leon-Cruz, C Godfrey, EY Chiao, ... Clinical Infectious Diseases 67 (9), 1339-1346, 2018 | 143 | 2018 |